← Back to Clinical Trials
Recruiting NCT07249515

Scapula and Upper Extremity Performance in Scoliosis

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Adolescent Idiopathic Scoliosis
Sponsor Istinye University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 20
Sex ALL
Min Age 10 Years
Max Age 19 Years
Start Date 2025-11-20
Completion 2026-02-15
Interventions
Assessment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Adolescent Idiopathic Scoliosis s a three-dimensional spinal deformity that may alter shoulder girdle alignment, scapular orientation, and upper extremity biomechanics. Changes in scapular position can influence arm movement, muscle activation, and overall functional performance. Understanding these relationships is clinically important for developing effective exercise and rehabilitation strategies. The aim of this study is to examine the association between scapular position and upper extremity performance in adolescents diagnosed with Adolescent Idiopathic Scoliosis. Scapular dyskinesis, scapular lateral displacement, and upper limb functional performance will be evaluated and correlated with Cobb angle severity. Findings may help clinicians better understand functional impairments linked to scoliosis and support more targeted rehabilitation programs.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of Adolescent Idiopathic Scoliosis * Age 10-19 years * Cobb angle between 10° and 45° * No prior scoliosis-specific conservative treatment * Ability to participate in physical assessments * Voluntary willingness to participate Exclusion Criteria: * Neuromuscular, congenital, or syndromic scoliosis * Prior spinal surgery * Shoulder injury or upper limb pathology affecting performance * Neurological or rheumatological disorders * Communication or cognitive limitations interfering with testing

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}